Savient Pharmaceuticals, Inc. Bankruptcy New Filing Alert: Required Bankruptcy Report Regarding To Initiate An Adversary Proceeding

On January 6, 2016, a required bankruptcy report regarding to initiate an adversary proceeding was filed in the bankruptcy case of Savient Pharmaceuticals, Inc. and its affiliates.

The filing was assigned docket number 896 and is described on the court’s official docket as follows:

Status Report on Open Preference Adversary Actions Assigned to the Honorable Mary F. Walrath Filed by Robert Rosenberg LLC. (Gellert, Ronald)

Savient Pharmaceuticals, Inc. filed for bankruptcy protection, or had an involuntary bankruptcy petition filed against it, on October 14, 2013. The bankruptcy case is pending before the United States Bankruptcy Court for the District of Delaware. The case number for the lead bankruptcy case is 13-12680. The bankruptcy case is currently assigned to United States Bankruptcy Judge Mary Walrath. The law firm of Skadden, Arps, Slate, Meagher & Flom LLP is acting as lead bankruptcy counsel to Savient Pharmaceuticals, Inc. in the bankruptcy case.


Leave a Reply